Niche-mediated depletion of the normal hematopoietic stem cell reservoir by Flt3-ITD-induced myeloproliferation.
Mead AJ. et al, (2017), The Journal of experimental medicine, 214, 2005 - 2021
COMBINATION OF DEEP PHENOTYPING AND TARGETED NEXT GENERATION SEQUENCING AS A DIAGNOSTIC TOOL IN CHILDREN WITH SUSPECTED MDS
Louka E. et al, (2017), HAEMATOLOGICA, 102, 265 - 265
COMPARISONS OF PATIENT MANAGEMENT IN MYELOPROLIFERATIVE NEOPLASM PATIENTS IN THE UK VS REST OF WORLD: ANALYSIS FROM THE INTERNATIONAL LANDMARK SURVEY
Harrison C. et al, (2017), HAEMATOLOGICA, 102, 813 - 814
COMPARISONS OF SYMPTOM BURDEN IN MYELOPROLIFERATIVE NEOPLASM PATIENTS IN THE UK VS REST OF WORLD: ANALYSIS FROM THE INTERNATIONAL LANDMARK SURVEY
Harrison C. et al, (2017), HAEMATOLOGICA, 102, 815 - 816
DISRUPTION OF HAEMATOPOIETIC STEM CELL HETEROGENEITY IN A MOUSE MODEL OF MYELOPROLIFERATIVE NEOPLASM
Norfo R. et al, (2017), HAEMATOLOGICA, 102, 149 - 150
RE-ORDERING THE B CELL DEVELOPMENT HIERARCHY IN HUMAN FETAL BONE MARROW: CHARACTERISATION OF A NOVEL HUMAN FETAL B PROGENITOR
O'Byrne S. et al, (2017), HAEMATOLOGICA, 102, 80 - 80
Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia.
Giustacchini A. et al, (2017), Nat Med, 23, 692 - 702
Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial.
Mesa RA. et al, (2017), Lancet Haematol, 4, e225 - e236
Equivalence of BCSH and WHO diagnostic criteria for ET.
Harrison CN. et al, (2017), Leukemia, 31, 527 - 528
Guideline for the investigation and management of eosinophilia
Butt NM. et al, (2017), British Journal of Haematology, 176, 553 - 572
Initial seeding of the embryonic thymus by immune-restricted lympho-myeloid progenitors.
Luis TC. et al, (2016), Nat Immunol, 17, 1424 - 1435
Ruxolitinib is effective in patients with intermediate-1 risk myelofibrosis: a summary of recent evidence
Harrison CN. et al, (2016), Leukemia and Lymphoma, 57, 2259 - 2267
Loss of Bone Marrow Mesenchymal Stem Cells in Myeloproliferative Neoplasms as an Indicator of Niche Dysregulation
Bishop E. et al, (2016), JOURNAL OF PATHOLOGY, 240, 23 - 23
EMBRYONIC THYMOPOIESIS IS INITIATED BY AN IMMUNE-RESTRICTED LYMPHO-MYELOID PROGENITOR INDEPENDENTLY OF NOTCH SIGNALING
Luis TC. et al, (2016), EXPERIMENTAL HEMATOLOGY, 44, S65 - S65
Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage.
Quek L. et al, (2016), The Journal of experimental medicine, 213, 1513 - 1535
Distinct myeloid progenitor differentiation pathways identified through single cell RNA sequencing
Nerlov C. et al, (2016), Nature Immunology
RUXOLITINIB COMPARED WITH BEST AVAILABLE THERAPY FOR ESSENTIAL THROMBOCYTHAEMIA PATIENTS RESISTANT OR INTOLERANT TO HYDROXYCARBAMIDE IN MAJIC - AN INVESTIGATOR LEAD RANDOMIZED TRIAL
Harrison C. et al, (2016), HAEMATOLOGICA, 101, 97 - 97
SINGLE-CELL PROFILING OF HUMAN MEGAKARYOCYTE-ERYTHROID PROGENITORS IDENTIFIES DISTINCT MEGAKARYOCYTE AND ERYTHROID DIFFERENTIATION PATHWAYS
Psaila B. et al, (2016), HAEMATOLOGICA, 101, 21 - 21